Reply :  by Kadoi, Yuji & Saito, Shigeru
The Journal of Thoracic and
Cardiovascular Surgery
Volume 119, Number 1
Letters to the Editor 189
Balloon pump–induced pulsatile perfusion during
cardiopulmonary bypass does not improve brain
oxygenation
To the Editor:
We read with interest the article by Kawahara and associ-
ates regarding the effects of pulsatile versus nonpulsatile per-
fusion on internal jugular venous oxygen saturation and
regional cerebral venous oxygen saturation during normoth-
ermic cardiopulmonary bypass (CPB) in 22 patients.1 They
have concluded that when compared with nonpulsatile flow,
pulsatile perfusion generated by an intra-aortic balloon pump
had no beneficial effect on cerebral protection.
The authors stated that although many methods have been
used to generate pulse pressure during CPB, no general defi-
nition and no criteria have been reported for pulsatile perfu-
sion. In contrast, the literature reports that several investiga-
tors have attempted to establish a common criterion for
pulsatile and nonpulsatile flow.2-6 Shepard, Simpson, and
Sharp2 suggested that the energy equivalent pressure (EEP)
formula may be used to quantify pulsatile and nonpulsatile
waveforms. The generation of the pulsatile flow depends on
the energy gradient rather than the pressure gradient. EEP
contains both pump flow and arterial pressure waveforms.
The following formula is used to define the EEP:
EEP = (∫fpdt)/(∫fdt)
where p is the arterial pressure, f is the pump flow, and dt is
the change in time at the end of flow and pressure cycles. The
units for EEP are millimeters of mercury. EEP is the ratio of
the area under the hemodynamic power curve (∫fpdt) and the
flow curve (∫fdt) at the end of flow and pressure cycles. 
Recently, we have quantified pulsatile and nonpulsatile
waveforms in terms of EEP.7 With an identical pump flow rate
and mean arterial pressure, the pulsatile roller pump (Stöckert
SIII, Munich, Germany) generated significantly higher EEP
than did conventional nonpulsatile perfusion. In addition, we
have shown that this increase in EEP maintained higher
regional and global cerebral, renal, and myocardial blood flow
in a neonatal piglet model.8 In a separate study with a differ-
ent pulsatile roller pump (Jostra HL-20, Jostra USA, Austin,
Tex), we have shown that regional cerebral venous oxygen sat-
uration increased during normothermic and hypothermic CPB
in a neonatal piglet model.9 In this particular study, EEP was
significantly higher than mean arterial pressure.
Our experience leads us to the conclusion that EEP is the
most complete formula to quantify pulsatile and nonpulsatile
waveforms for direct comparisons. 
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Reply to the Editor:
We appreciate the interest and comments of Drs Ündar and
Fraser. Several investigators1 have tried to establish common
criteria for pulsatile flow, but it is not clear which type of pul-
satile waveform has positive effects on cerebral circulation and
improves outcome of patients.2 As stated by Ündar and associ-
ates,3 it is impossible to compare the results of different inves-
tigations in which different types of pulsatility were used.
We can see that the concept of energy equivalent pressure
introduced by Shepard, Simpson, and Sharp4 is useful for
understanding the quality of pulsatile perfusion. Wright5
believes that hemodynamic considerations were fundamental
to resolve the controversy of the pulsatility waveform. We
hope that further clinical investigations will determine the
best pulsatile form and will be supported by logical theories,
such as energy equivalent pressure.
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Is the use of topical vancomycin to prevent medias-
tinitis after cardiac surgery justified?
To the Editor:
Patients undergoing cardiopulmonary bypass (CPB) are at
substantial risk of acquiring infections because of the
increased number of potential ports of entry of pathogens in
the presence of CPB-induced impairment of immune
responses.1 Despite regular use of prophylactic intravenous
antibiotics, postoperative mediastinitis occurs in 0.4% to 5%
of patients undergoing cardiac operations.1 This complication
is associated with a 14% to 47% risk of in-hospital mortality.1
Gram-positive bacteria are the most common isolates from
patients with mediastinitis; Staphylococcus aureus and
Staphylococcus epidermidis are identified in 70% to 80% of
cases.1 In a prospective randomized controlled study, Vander
Salm and associates2 found that topical vancomycin applied
during wound closure after median sternotomy was associat-
ed with a significant reduction in the rate of sternal wound
infection. Although this study has not been repeated, its find-
ings were accepted by a number of cardiac surgeons who
have adopted the routine use of topical vancomycin powder
to prevent mediastinitis after CPB (unpublished data).
The risk of vancomycin resistance has been a concern of
those who have adopted this approach. However, 2 factors
have supported the use of vancomycin for this purpose. First,
the drug is instilled in a confined space, which prevents free
movements of organisms in and out of the area at risk. Second,
topical application of vancomycin was believed to result in
insignificant serum levels. We have studied the pharmacoki-
netics of vancomycin powder instilled between the edges of
the sternum during closure of the median sternotomy in 4
patients undergoing CPB. Contrary to the common belief that
topical vancomycin powder is poorly absorbed, levels up to
4.4 mg/L were found in the patients’ serum within 3 to 4 hours
after topical application of 1 g of vancomycin powder (Fig 1).
Recent emergence of vancomycin resistance in methicillin-
resistant S aureus3-5 could raise doubts regarding the wisdom
of continuing this approach. The first report of vancomycin
resistance in methicillin-resistant S aureus occurred after a
cardiac operation in a 4-month-old boy.3 More recently,
Smith and colleagues4 have identified 2 more cases of S
aureus with intermediate resistance to vancomycin. The
mechanism of resistance, however, is not due to the acquisi-
tion of the feared vanA or vanB resistance genes that have
been isolated from vancomycin-resistant enterococci.5 S
aureus–intermediate resistance to vancomycin is believed to
be mediated by accumulation of cell wall components, with
possible alternative vancomycin-binding pathways that divert
vancomycin from its target site.
We wish to debate this issue among the cardiothoracic sur-
geons and the experts in the field of antibiotic resistance.
Such a debate will undoubtedly help to determine the risks
versus the benefits of using topical vancomycin to prevent
mediastinitis after median sternotomy.
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Fig 1. Vancomycin levels before and after instillation of 1 g
of vancomycin powder between the sternal edges during
wound closure. Vancomycin serum levels were measured
before the operation and 1, 3, 6, 24, and 48 hours after instil-
lation of vancomycin. The solid line represents the mean
value of vancomycin levels in milligrams per liter obtained
from 4 patients. The mean values are 0.1, 2.1, 2.2, 1.4, 1.2,
and 0.8 mg/L, respectively.
